5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment.
Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of illness and treatment suitability. In this pilot, we examined nine patients with amnestic mild cognitive impairment (MCI) and 10 age and edu...
Main Authors: | Terrière, E, Dempsey, M, Herrmann, L, Tierney, K, Lonie, J, O'Carroll, R, Pimlott, S, Wyper, D, Herholz, K, Ebmeier, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
alpha4beta2-nicotinic receptor binding with 5-IA in Alzheimer's disease: methods of scan analysis.
by: Terrière, E, et al.
Published: (2008) -
MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging.
by: Sexton, C, et al.
Published: (2010) -
Dual task performance in early Alzheimer's disease, amnestic mild cognitive impairment and depression.
by: Lonie, J, et al.
Published: (2009) -
Predicting outcome in mild cognitive impairment: 4-year follow-up study.
by: Lonie, J, et al.
Published: (2010) -
Screening for mild cognitive impairment: a systematic review.
by: Lonie, J, et al.
Published: (2009)